Clinique Victor Hugo, Centre Cancérologie de la Sarthe
- Address
- 64-66 rue de Degré, 72000 Le Mans, France
Clinique Victor Hugo, Centre Cancérologie de la Sarthe - Oncology Research Center
The Clinique Victor Hugo, Centre Cancérologie de la Sarthe is a specialized oncology research facility dedicated to advancing cancer treatment through participation in innovative clinical trials. The center focuses on evaluating novel therapeutic approaches for challenging malignancies, with particular emphasis on hormone-resistant and aggressive cancer subtypes that require advanced treatment strategies.
- Metastatic castration-resistant prostate cancer treatments and targeted antibody-drug conjugates
- Triple-negative breast cancer neoadjuvant and adjuvant immunotherapy combinations
- Phase III randomized controlled trials evaluating chemotherapy plus immunotherapy regimens
The center's research portfolio demonstrates expertise in complex genitourinary and breast oncology protocols, including studies that assess radiographic progression-free survival and pathological complete response rates. By participating in multinational trials involving both antibody-drug conjugates and checkpoint inhibitor immunotherapies, the center contributes to the development of precision medicine approaches for patients with advanced malignancies, offering access to cutting-edge treatments before they become widely available.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique Victor Hugo, Centre Cancérologie de la Sarthe
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Randomized, Open-Label Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-Resistant Prostate Cancer (TAMARACK) | Macrogenics Inc. | Phase II | Not Recruiting | May 2023 | Jan 2025 |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anhydrous Cyclophosphamide | 1 | Unknown | 2017-03-07 | 2017-03-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.